1. Home
  2. ASRT

ASRT

Assertio Holdings Inc.

Logo Assertio Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Founded: 1995 Country:
United States
United States
Employees: N/A City: LAKE FOREST
Market Cap: 73.4M IPO Year: 1997
Target Price: $3.50 AVG Volume (30 days): 908.9K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.67 EPS Growth: N/A
52 Week Low/High: $0.77 - $8.01 Next Earning Date: 05-07-2024
Revenue: $152,069,000 Revenue Growth: -2.67%
Revenue Growth (this year): -21.29% Revenue Growth (next year): 10.86%

Share on Social Networks: